Logo image of USAK

USA TRUCK INC (USAK) Stock Fundamental Analysis

NASDAQ:USAK - Nasdaq - US9029251066 - Common Stock - Currency: USD

31.71  +0.01 (+0.03%)

After market: 31.73 +0.02 (+0.06%)

Fundamental Rating

3

Taking everything into account, USAK scores 3 out of 10 in our fundamental rating. USAK was compared to 39 industry peers in the Ground Transportation industry. Both the profitability and financial health of USAK have multiple concerns. USAK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

USAK had positive earnings in the past year.
USAK Yearly Net Income VS EBIT VS OCF VS FCFUSAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M 60M

1.2 Ratios

Industry RankSector Rank
ROA 8.09%
ROE 25.93%
ROIC 10.36%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USAK Yearly ROA, ROE, ROICUSAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20

1.3 Margins

Industry RankSector Rank
OM 5.51%
PM (TTM) 4.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USAK Yearly Profit, Operating, Gross MarginsUSAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

USAK has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, USAK has more shares outstanding
The debt/assets ratio for USAK has been reduced compared to a year ago.
USAK Yearly Shares OutstandingUSAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M
USAK Yearly Total Debt VS Total AssetsUSAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

USAK has an Altman-Z score of 3.38. This indicates that USAK is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.96 indicates that USAK is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.38
ROIC/WACC1.15
WACC9.04%
USAK Yearly LT Debt VS Equity VS FCFUSAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M

2.3 Liquidity

USAK has a Current Ratio of 1.22. This is a normal value and indicates that USAK is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.21 indicates that USAK should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.21
USAK Yearly Current Assets VS Current LiabilitesUSAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

USAK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 108.33%, which is quite impressive.
Measured over the past years, USAK shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.99% on average per year.
Looking at the last year, USAK shows a very strong growth in Revenue. The Revenue has grown by 24.78%.
Measured over the past years, USAK shows a quite strong growth in Revenue. The Revenue has been growing by 10.61% on average per year.
EPS 1Y (TTM)108.33%
EPS 3Y22.68%
EPS 5Y30.99%
EPS Q2Q%14%
Revenue 1Y (TTM)24.78%
Revenue growth 3Y9.97%
Revenue growth 5Y10.61%
Sales Q2Q%18.88%

3.2 Future

USAK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.47% yearly.
USAK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.05% yearly.
EPS Next Y37.42%
EPS Next 2Y-0.77%
EPS Next 3Y15.5%
EPS Next 5Y14.47%
Revenue Next Year17.91%
Revenue Next 2Y7.38%
Revenue Next 3Y7.4%
Revenue Next 5Y5.05%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
USAK Yearly Revenue VS EstimatesUSAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
USAK Yearly EPS VS EstimatesUSAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

USAK is valuated cheaply with a Price/Earnings ratio of 7.93.
USAK is valuated cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 11.18, the valuation of USAK can be described as very reasonable.
When comparing the Price/Forward Earnings ratio of USAK to the average of the S&P500 Index (22.70), we can say USAK is valued rather cheaply.
Industry RankSector Rank
PE 7.93
Fwd PE 11.18
USAK Price Earnings VS Forward Price EarningsUSAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.59
USAK Per share dataUSAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

USAK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
USAK's earnings are expected to grow with 15.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)0.26
EPS Next 2Y-0.77%
EPS Next 3Y15.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for USAK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

USA TRUCK INC

NASDAQ:USAK (9/14/2022, 8:00:51 PM)

After market: 31.73 +0.02 (+0.06%)

31.71

+0.01 (+0.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)08-08 2022-08-08/amc
Earnings (Next)10-26 2022-10-26
Inst Owners0.88%
Inst Owner Change0%
Ins Owners8.47%
Ins Owner Change0%
Market Cap286.46M
Analysts80
Price Target32.35 (2.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.93
Fwd PE 11.18
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB N/A
EV/EBITDA 5.59
EPS(TTM)4
EY12.61%
EPS(NY)2.84
Fwd EY8.94%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS86.9
BVpS14.21
TBVpSN/A
PEG (NY)0.21
PEG (5Y)0.26
Profitability
Industry RankSector Rank
ROA 8.09%
ROE 25.93%
ROCE N/A
ROIC 10.36%
ROICexc N/A
ROICexgc 11.04%
OM 5.51%
PM (TTM) 4.24%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.21
Altman-Z 3.38
F-Score7
WACC9.04%
ROIC/WACC1.15
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.33%
EPS 3Y22.68%
EPS 5Y30.99%
EPS Q2Q%14%
EPS Next Y37.42%
EPS Next 2Y-0.77%
EPS Next 3Y15.5%
EPS Next 5Y14.47%
Revenue 1Y (TTM)24.78%
Revenue growth 3Y9.97%
Revenue growth 5Y10.61%
Sales Q2Q%18.88%
Revenue Next Year17.91%
Revenue Next 2Y7.38%
Revenue Next 3Y7.4%
Revenue Next 5Y5.05%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A